Real-World Outcomes of Dual Advanced Therapy in Inflammatory Bowel Disease

被引：0
|
作者：
Kellar, Amelia [1 ]
Dolinger, Michael [1 ]
Spencer, Elizabeth [1 ]
Dubinsky, Marla C. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 12S期
关键词：
D O I：
10.14309/01.ajg.0000995772.48171.4c
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S135
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [41] A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence
    Wong, Charlotte
    van Oostrom, Joep
    Bossuyt, Peter
    Pittet, Valerie
    Hanzel, Jurij
    Samaan, Mark
    Tripathi, Monika
    Czuber-Dochan, Wladyslawa
    Burisch, Johan
    Leone, Salvatore
    Saldana, Roberto
    Baert, Filip
    Kopylov, Uri
    Jaghult, Susanna
    Adamina, Michel
    Gecse, Krisztina
    Arebi, Naila
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (10): : 1511 - 1522
  • [42] Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease
    Patel, Haridarshan
    Latremouille-Viau, Dominick
    Burne, Rebecca
    Shi, Sherry
    Adsul, Shashi
    CROHNS & COLITIS 360, 2019, 1 (02)
  • [43] Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data
    Goss Sawhney, Tia
    Dobes, Angela
    O'Charoen, Sirimon
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [44] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
  • [45] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S74 - S75
  • [46] Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
    Markovic, S.
    Kralj, D.
    Ivanovski, T. Knezevic
    Kalaba, A.
    Odanovic, O.
    Homsek, A.
    Svorcan, P.
    Vucicevic, K.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1231 - I1231
  • [47] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
  • [48] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [49] Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience
    Cleveland, Noa Krugliak
    Choi, Natalie
    Choi, David K.
    Dalal, Sushila
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S873 - S874
  • [50] Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
    Smith, Philip J.
    Fumery, Mathurin
    Leong, Rupert W.
    Novak, Kerri
    Dignass, Axel
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (09) : 1143 - 1156
12345